The Current Ratio as of December 2025 (TTM) for Jafron Biomedical Co.,Ltd. (300529.SZ) is 4.26

According to Jafron Biomedical Co.,Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 4.26. This represents a change of 10.61% compared to the average of 3.85 of the last 4 quarters.

Jafron Biomedical Co.,Ltd. (300529.SZ) Historical Current Ratio (quarterly & annually)

How has 300529.SZ Current Ratio performed in the past?

The mean historical Current Ratio of Jafron Biomedical Co.,Ltd. over the last ten years is 5.77. The current 4.26 Current Ratio has changed 7.28% with respect to the historical average. Over the past ten years (40 quarters), 300529.SZ's Current Ratio was at its highest in in the September 2016 quarter at 14.29. The Current Ratio was at its lowest in in the March 2024 quarter at 2.99.

Jafron Biomedical Co.,Ltd. (300529.SZ) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Jafron Biomedical Co.,Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jafron Biomedical Co.,Ltd. (300529.SZ) Average Current Ratio

How has 300529.SZ Current Ratio performed in the past?

The current Current Ratio of Jafron Biomedical Co.,Ltd. (300529.SZ) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Jafron Biomedical Co.,Ltd. (300529.SZ) Current Ratio vs. Peers

How is 300529.SZ’s Current Ratio compared to its peers?

Jafron Biomedical Co.,Ltd.’s Current Ratio is less than Autek China Inc. (5.10), less than Shanghai MicroPort Endovascular MedTech Co., Ltd. (4.75), greater than Micro-Tech (Nanjing) Co., Ltd. (4.02), greater than Zhejiang Jingxin Pharmaceutical Co., Ltd. (1.62), greater than Pacific Shuanglin Bio-pharmacy Co., Ltd. (2.93), greater than China Meheco Group Co., Ltd. (1.43), greater than Qingdao Baheal Medical Inc. (1.55), greater than Yifan Pharmaceutical Co., Ltd. (1.27), greater than China National Accord Medicines Corporation Ltd. (1.50), greater than Tibet Rhodiola Pharmaceutical Holding Co. (3.02),

Build a custom stock screener for Jafron Biomedical Co.,Ltd. (300529.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jafron Biomedical Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jafron Biomedical Co.,Ltd. (300529.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jafron Biomedical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.